Hosted on MSN38m
JMP Securities Initiates Coverage of Context Therapeutics (CNTX) with Market Outperform RecommendationFintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback